Efficacy, safety, and tolerability of desvenlafaxine 50 mg/day and 100 mg/day in outpatients with major depressive disorder
Year: 2008
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Institutions: Columbia University, Wyeth
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: desvenlafaxine, major depressive disorder, serotonin-norepinephrine reuptake inhibitors, dose comparison, antidepressant efficacy, adverse events, tolerability, outpatients, Hamilton Depression Rating Scale, pain intensity, xerostomia, constipation, insomnia, hyperhidrosis, dizziness, appetite loss, comorbidities, treatment-resistant depression
Open Access status: closed
OpenAlex ID: W2078627160
